Peripheral Neuropathy in HIV-infected Children Attending Care and Treatment Clinic, at Muhimbili National Hospital, Dar Es Salaam: a Cross Sectional Study

Overview

Journal BMC Neurol

Publisher Biomed Central

Specialty Neurology

Date 2021 Aug 14

PMID 34388988

Citations 1

Authors

Insiyah A Amiji

Helga E Naburi

Edward Kija

Livin P Mumburi

Affiliations

Soon will be listed here.

Abstract

Background: Peripheral neuropathy (PN) is a neurological complication of untreated Human Immunodeficiency Virus (HIV) infection or exposure to certain antiretroviral drugs. In Tanzania where HIV is a major public health problem, the burden of HIV associated peripheral neuropathy has not yet been well defined in children.Thisstudy investigated the prevalence and associated factors for peripheral neuropathy among children living with HIV, attending Care and Treatment Clinic (CTC) at Muhimbili National Hospital (MNH).

Materials And Methods: A cross-sectional study was conducted among 383 HIV positive children aged 5 to 18 years at MNH, CTC in Dar es Salaam between October to December 2019. All participants provided written assent/consent. Structured questionnaires designed for this study was used to collect data and screening for peripheral neuropathy was done on each participant using the Pediatric modified Total Neuropathy Score (Ped m TNS) that includes subjective and objective assessment. A score of 5 or greater on the Ped m TNS was used to define peripheral neuropathy. Data analysis was done using SPSS Version 23.

Results: The prevalence of peripheral neuropathy among HIV infected children was 14.1 % (95 % CI (10.8 - 18 %). Common neuropathic symptoms were numbness, tingling sensation, reduced ankle reflexes and reduced sensation to light touch and pain that was limited to the toes. Low CD4 cell count (OR = 12.21; 95 % CI3.75-39.66; p = 0.0001), high viral load (OR = 10.54; 95 % CI 3.19-34.77; p = 0.0001), ART regime containing NRTI plus PI (OR = 3.93; 95 % CI 1.43- 10.74; p = 0.01) and the last exposure to isoniazid more than 6 months ago (OR = 3.71; 95 % CI 1.57-8.77; p = 0.003) were independent predictors for peripheral neuropathy.

Conclusion: Peripheral neuropathy is common among HIV infected children attending CTC at MNH and its frequency increases with advanced disease. The choice of ART regimen and other drugs for treating comorbid conditions should carefully be evaluated.

Citing Articles

Peripheral neuropathy and associated factors among children living with HIV on antiretroviral therapy in Gamo zone, Southern Ethiopia: an institution-based cross-sectional study.

Wondmagegn H, Birhanu A, Gebremickael A, Esubalew H, Birhanu M, Gembe M BMC Infect Dis. 2024; 24(1):1059.

PMID: 39334011 PMC: 11428338. DOI: 10.1186/s12879-024-09984-9.

References

Smyth K, Affandi J, McArthur J, Bowtell-Harris C, Mijch A, Watson K . Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993-2006. HIV Med. 2007; 8(6):367-73. DOI: 10.1111/j.1468-1293.2007.00478.x. View

Tagliati M, Grinnell J, Godbold J, Simpson D . Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings. Arch Neurol. 1999; 56(1):84-9. DOI: 10.1001/archneur.56.1.84. View

Zaoui A, Abdelghani A, Ben Salem H, Ouanes W, Hayouni A, Khachnaoui F . Early-onset severe isoniazid-induced motor-dominant neuropathy: a case report. East Mediterr Health J. 2012; 18(3):298-9. DOI: 10.26719/2012.18.3.298. View

Araujo A, Nascimento O, Garcia O . Distal sensory polyneuropathy in a cohort of HIV-infected children over five years of age. Pediatrics. 2000; 106(3):E35. DOI: 10.1542/peds.106.3.e35. View

Esteban P, Thahn T, Bravo J, Roca L, Quispe N, Montano S . Malnutrition associated with increased risk of peripheral neuropathy in Peruvian children with HIV infection. J Acquir Immune Defic Syndr. 2009; 52(5):656-8. PMC: 3514441. DOI: 10.1097/QAI.0b013e3181bb268d. View

Morgan K, Anghelescu D . A Review of Adult and Pediatric Neuropathic Pain Assessment Tools. Clin J Pain. 2016; 33(9):844-852. DOI: 10.1097/AJP.0000000000000476. View

Shetty N, Shah I . Isoniazid-induced neuropathy in a pre-pubertal child. Paediatr Int Child Health. 2018; 39(3):216-218. DOI: 10.1080/20469047.2018.1482996. View

Cherry C, Wesselingh S, Lal L, McArthur J . Evaluation of a clinical screening tool for HIV-associated sensory neuropathies. Neurology. 2005; 65(11):1778-81. DOI: 10.1212/01.wnl.0000187119.33075.41. View

Govender R, Eley B, Walker K, Petersen R, Wilmshurst J . Neurologic and neurobehavioral sequelae in children with human immunodeficiency virus (HIV-1) infection. J Child Neurol. 2011; 26(11):1355-64. DOI: 10.1177/0883073811405203. View

10.

Schutz S, Robinson-Papp J . HIV-related neuropathy: current perspectives. HIV AIDS (Auckl). 2013; 5:243-51. PMC: 3775622. DOI: 10.2147/HIV.S36674. View

11.

Wadley A, Cherry C, Price P, Kamerman P . HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans. J Pain Symptom Manage. 2010; 41(4):700-6. DOI: 10.1016/j.jpainsymman.2010.07.006. View

12.

Balt C . An investigation of the relationship between vitamin B12 deficiency and HIV infection. J Assoc Nurses AIDS Care. 2000; 11(1):24-8, 31-5. DOI: 10.1016/S1055-3290(06)60419-6. View

13.

Saylor D, Nakigozi G, Nakasujja N, Robertson K, H Gray R, J Wawer M . Peripheral neuropathy in HIV-infected and uninfected patients in Rakai, Uganda. Neurology. 2017; 89(5):485-491. PMC: 5539731. DOI: 10.1212/WNL.0000000000004136. View

14.

So Y, Holtzman D, Abrams D, Olney R . Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based survey. Arch Neurol. 1988; 45(9):945-8. DOI: 10.1001/archneur.1988.00520330023005. View

15.

Ellis R, Marquie-Beck J, Delaney P, Alexander T, Clifford D, McArthur J . Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy. Ann Neurol. 2008; 64(5):566-72. PMC: 2605176. DOI: 10.1002/ana.21484. View

16.

Floeter M, Civitello L, EVERETT C, Dambrosia J, Luciano C . Peripheral neuropathy in children with HIV infection. Neurology. 1997; 49(1):207-12. DOI: 10.1212/wnl.49.1.207. View

17.

Peters R, van Ramshorst M, Struthers H, McIntyre J . Clinical assessment of peripheral neuropathy in HIV-infected children on antiretroviral therapy in rural South Africa. Eur J Pediatr. 2014; 173(9):1245-8. DOI: 10.1007/s00431-014-2303-9. View

18.

Smolik S, Arland L, Hensley M, Schissel D, Shepperd B, Thomas K . Assessment Tools for Peripheral Neuropathy in Pediatric Oncology: A Systematic Review From the Children's Oncology Group. J Pediatr Oncol Nurs. 2018; 35(4):267-275. PMC: 5988942. DOI: 10.1177/1043454218762705. View

19.

Gilchrist L, Tanner L . The pediatric-modified total neuropathy score: a reliable and valid measure of chemotherapy-induced peripheral neuropathy in children with non-CNS cancers. Support Care Cancer. 2012; 21(3):847-56. DOI: 10.1007/s00520-012-1591-8. View

20.

Skopelitis E, Kokotis P, Kontos A, Panayiotakopoulos G, Konstantinou K, Kordossis T . Distal sensory polyneuropathy in HIV-positive patients in the HAART era: an entity underestimated by clinical examination. Int J STD AIDS. 2006; 17(7):467-72. DOI: 10.1258/095646206777689062. View